MedPath

A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agonists

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000048407
Lead Sponsor
Kanto Rosai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
65
Inclusion Criteria

Not provided

Exclusion Criteria

1) a history of hospitalization to improve glycemic control within the past 3 months 2) considered to be ineligible for other reasons at the discretion of the attending physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the proportion of patients who selected oral or injectable semaglutide
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath